Cleared Traditional

K131245 - OREGON SCINTIFIC

K131245 is the FDA 510(k) clearance for OREGON SCINTIFIC by Idt Technology Limited. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 261-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2014
Decision
261d
Days
Class 2
Risk

K131245 is an FDA 510(k) clearance for the OREGON SCINTIFIC. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Idt Technology Limited (Shenzhen,, CN). The FDA issued a Cleared decision on January 17, 2014 after a review of 261 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Idt Technology Limited devices

Submission Details

510(k) Number K131245 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 2013
Decision Date January 17, 2014
Days to Decision 261 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
136d slower than avg
Panel avg: 125d · This submission: 261d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 501
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K131245.
FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K140121 · Andon Health Co, Ltd. · Jul 2014
EV1000 CLINICAL PLATFORM WITH CLEARSIGHT TM FINGER CUFF OR CLEARSIGHT TM SYSTEM
K140312 · Edwards Lifesciences, LLC · Jun 2014
HEM-7320
K133383 · Omron Healthcare, Inc. · Mar 2014
HEM-7311
K133379 · Omron Healthcare, Inc. · Jan 2014
HEM-6221
K131749 · Omron Healthcare, Inc. · Oct 2013
HEM-6131
K131742 · Omron Healthcare, Inc. · Jul 2013